Article
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2000
Hutchinson P E, Osborne J E, Lear J T, Smith A G, Bowers P W, Morris P N, Jones P W, York C, Strange R C, Fryer A A
Abstract excerpt
Calcitriol [1,25(OH)2D3], the hormonal derivative of vitamin D3, is an antiproliferative and prodifferentiation factor for several cell types, including cultured melanocytes and malignant melanoma (MM) cells. Several polymorphisms of the vitamin D receptor (VDR) gene have been described including a FokI RFLP in exon 2, BsmI, and ApaI polymorphisms in intron 8 and an adjacent TaqI RFLP in exon 9. Alterations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
